In 2024, Merck & Co., Inc. (NYSE: MRK ) was the third-largest pharmaceutical company in the world by revenue, making $64.2 billion, ranking just behind China's Sinopharm and Switzerland's Roche. It was followed closely by Pfizer (I’ve managed my investments since 1999, gaining perspective across multiple market cycles. With a background in Economics from the University of Tartu and ongoing CFA certification, I focus on uncovering deeply undervalued equities with long-term potential often overlooked by the m ...